{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:24:06Z","timestamp":1790389446574,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.acvd.2020.04.007","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:43:05Z","timestamp":1595439785000},"page":"652-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Colchicine and myocardial infarction: A review"],"prefix":"10.1016","volume":"113","author":[{"given":"Mariama","family":"Akodad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Fauconnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2020.04.007_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.acvd.2020.04.007_bib0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signalling in cardiac ischemia","volume":"8","author":"Arslan","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.revmed.2008.01.026","article-title":"C-reactive protein (CRP) after revascularised STEMI: is CRP a prognostic factor?","volume":"29","author":"Roubille","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.acvd.2020.04.007_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/14728214.2013.811487","article-title":"Inflammation and the heart \u2013 prime time for new therapeutic approaches","volume":"18","author":"Roubille","year":"2013","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.acvd.2020.04.007_bib0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0306-9877(92)90043-C","article-title":"Proposal for clinical trials using anti-inflammatory drugs in the therapy of angina pectoris, myocardial infarction and coronary restenosis after angioplasty and bypass grafting","volume":"37","author":"Chaldakov","year":"1992","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.acvd.2020.04.007_bib0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1871523011312010004","article-title":"Colchicine: an old wine in a new bottle?","volume":"12","author":"Roubille","year":"2013","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1016\/j.acvd.2020.04.007_bib0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14779072.2013.839942","article-title":"Investigational drugs targeting cardiac fibrosis","volume":"12","author":"Roubille","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.acvd.2020.04.007_bib0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.cellbio.16.1.89","article-title":"Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics","volume":"16","author":"Downing","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/art.1780130207","article-title":"The early history of anti-rheumatic drugs","volume":"13","author":"Rodnan","year":"1970","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.acvd.2020.04.007_bib0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.acvd.2020.04.007_bib0270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2020.04.007_bib0275","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.acvd.2020.04.007_bib0280","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","article-title":"The role of interleukin-1 and the inflammasome in gout: implications for therapy","volume":"56","author":"Pope","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.acvd.2020.04.007_bib0285","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2017.03.126","article-title":"Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model","volume":"240","author":"Akodad","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0290","first-page":"195","article-title":"Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1","volume":"79","author":"Ono","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.acvd.2020.04.007_bib0295","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/01.CIR.0000092890.29552.22","article-title":"Anti-monocyte chemo-attractant protein-1 gene therapy attenuates left ventricular remodelling and failure after experimental myocardial infarction","volume":"108","author":"Hayashidani","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2020.04.007_bib0300","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.clinthera.2019.07.015","article-title":"Colchicine as a novel therapy for suppressing chemokine production in patients with an acute coronary syndrome: a pilot study","volume":"41","author":"Tucker","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.acvd.2020.04.007_bib0305","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M113.464461","article-title":"Control of myofibroblast differentiation by microtubule dynamics through a regulated localisation of mDia2","volume":"288","author":"Sandbo","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.acvd.2020.04.007_bib0310","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.4049\/jimmunol.180.12.7827","article-title":"Lysophospholipids and ATP mutually suppress maturation and release of IL-1 beta in mouse microglial cells using a Rho-dependent pathway","volume":"180","author":"Takenouchi","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0315","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1177\/089686080802805S11","article-title":"The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis","volume":"28","author":"Bozkurt","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.acvd.2020.04.007_bib0320","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00057.2013","article-title":"Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease","volume":"305","author":"Guan","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0325","first-page":"343","article-title":"The effect of colchicine on the development of experimental atherosclerosis in rabbits","volume":"38","author":"Wojcicki","year":"1986","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.acvd.2020.04.007_bib0330","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Martinez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2020.04.007_bib0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1620\/tjem.213.139","article-title":"Colchicine, a microtubule depolymerising agent, inhibits myocardial apoptosis in rats","volume":"213","author":"Saji","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.acvd.2020.04.007_bib0340","doi-asserted-by":"crossref","first-page":"e006195","DOI":"10.1161\/JAHA.117.006195","article-title":"Colchicine depolymerises microtubules, increases junctophilin-2, and improves right ventricular function in experimental pulmonary arterial hypertension","volume":"6","author":"Prins","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2020.04.007_bib0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/ajrccm\/137.1.181","article-title":"Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach to the fibrotic disorders","volume":"137","author":"Rennard","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.acvd.2020.04.007_bib0350","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1073\/pnas.89.4.1256","article-title":"Cardiostimulatory and anti-arrhythmic activity of tubulin-binding agents","volume":"89","author":"Lampidis","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.acvd.2020.04.007_bib0355","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1074248418763611","article-title":"Cardioprotective role of colchicine against inflammatory injury in a rat model of acute myocardial infarction","volume":"23","author":"Bakhta","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.acvd.2020.04.007_bib0360","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1253\/circj.CJ-16-0949","article-title":"Colchicine improves survival, left ventricular remodelling, and chronic cardiac function after acute myocardial infarction","volume":"81","author":"Fujisue","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.acvd.2020.04.007_bib0365","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00005344-199606000-00016","article-title":"Effect of colchicine on circulating and myocardial neutrophils and on infarct size in a canine model of ischemia and reperfusion","volume":"27","author":"Forrat","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0370","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1160\/TH16-03-0246","article-title":"Inflammation and thrombosis \u2013 testing the hypothesis with anti-inflammatory drug trials","volume":"116","author":"De Caterina","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2020.04.007_bib0375","first-page":"3427","article-title":"Colchicine treatment of recurrent steroid-dependent pericarditis in a patient with post-myocardial-infarction syndrome (Dressler's syndrome)","volume":"154","author":"Madsen","year":"1992","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.acvd.2020.04.007_bib0380","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0385","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2020.04.007_bib0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilisation in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2020.04.007_bib0395","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","article-title":"Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomised controlled trial","volume":"33","author":"Raju","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acvd.2020.04.007_bib0400","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2020.04.007_bib0405","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2020.04.007_bib0410","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomised placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2020.04.007_bib0415","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2020.04.007_bib0420","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.2174\/13816128113199990351","article-title":"Emerging anti-inflammatory therapies for atherosclerosis","volume":"19","author":"Roubille","year":"2013","journal-title":"Curr Pharm Des"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620301431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620301431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:46:44Z","timestamp":1761745604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213620301431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1875213620301431"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2020.04.007","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine and myocardial infarction: A review","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2020.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}